Title : Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis.

Pub. Date : 2021 Apr 23

PMID : 33922540






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The results suggest that polymorphisms detected in the GSTP1, ITGA4, NQO1, AKT1, and GP6 genes, for treatment with natalizumab, ZMIZ1, for fingolimod and dimethyl fumarate, ADA, for cladribine, and NOX3, for dimethyl fumarate, may be used in the future as predictive markers of treatment response to new therapies in MS patients. Fingolimod Hydrochloride glycoprotein VI platelet Homo sapiens